n/a
Article Publish Status: FREE
Abstract Title:

var.Improves Cognitive Impairment under Amyloid Beta-Induced Alzheimer's Disease Model.

Abstract Source:

Biomed Res Int. 2022 ;2022:4513998. Epub 2022 Jan 7. PMID: 35036433

Abstract Author(s):

Qi Qi Pang, Ji-Hyun Kim, Ji Myung Choi, Jia-Le Song, Sanghyun Lee, Eun Ju Cho

Article Affiliation:

Qi Qi Pang

Abstract:

Abnormal production and degradation of amyloid beta (A) in the brain lead to oxidative stress and cognitive impairment in Alzheimer's disease (AD).var.(CJM) is widely used as an herbal medicine and has antibacterial and anti-inflammatory properties. This study focused on the protective effect of the ethyl acetate fraction from CJM (ECJM) on A-induced control mice. In the T-maze and novel object recognition test, ECJM provided higher spatial memory and object recognition compared to Atreatment alone. In the Morris water maze test, ECJM-administered mice showed greater learning and memory abilities than A-induced control mice. Additionally, ECJM-administered mice experienced inhibited lipid peroxidation and nitric oxide production in a dose-dependent manner. The present study indicates that ECJM improves cognitive impairment by inhibiting oxidative stress in A-induced mice. Therefore, CJM may be useful for the treatment of AD and may be a potential material for functional foods.

Study Type : Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.